We have been so moved by the efforts of our great medical people fighting COVID-19 that Leguano Canada will donate 15% of all our online sales from now until April 15th 2020. Please read more about the amazing work they are doing below.
At the conclusion of this initiative on April 15th, 2020 the team at Leguano will draw a name from all the customers that purchased a pair of shoes during this time and reward that person with a brand new pair of any colour of the Active style as a gift from us to you!
Let’s get together and make a difference today!
The Leguano Team
Here are some of the details about the heroic efforts of Toronto’s Sunnybrook hospital.
Sunnybrook has been at the global forefront of the COVID-19 pandemic since the first Canadian case was identified. Our clinical response was immediate, but crucially, so was our research response.
Drs. Samira Mubareka and Robert Kozak have led Sunnybrook’s research response efforts since the earliest days of the pandemic. Their work has been globally significant, leading to early implementation of a hospital-based COVID-19 test. That test now serves at least six major hospitals and their associated assessment centres, including Sunnybrook. Our team has also established the foundation for a viral genomics research program that has already made important contributions to COVID-19 analysis.
Most crucially, on March 10, 2020, Sunnybrook scientists isolated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the ongoing outbreak of COVID-19.
Thanks to nimble collaboration, our team was able to culture the virus from two clinical specimens in a Level 3 containment facility. The isolated virus will help researchers in Canada and across the world develop better diagnostic testing, treatments and vaccines, and gain a better understanding of SARS-CoV-2 biology, evolution and clinical shedding.
Now that the virus has been isolated and a test created, with these crucial tools in hand, we propose an ambitious research program that builds upon existing facilities and expertise. This program will be led by Drs. Mubareka and Kozak, who are deeply experienced in viral transmission, diagnostics and vaccine development. The team will continue to collaborate closely with scientists at University of Toronto, McMaster and University of Laval to consolidate and focus our resources where they are needed most: stopping the COVID-19 pandemic.
Below is the endorsement letter from Sunnybrook to Leguano Inc. which also includes details of how you can donate directly to this amazing cause as well.